Azim Hossain
Overview
Explore the profile of Azim Hossain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Polcyn R, Capone M, Matzelle D, Hossain A, Chandran R, Banik N, et al.
Neurochem Int
. 2020 Jul;
139:104788.
PMID: 32650031
Enolase inhibition is a potential therapeutic strategy currently being investigated for treatment of spinal cord injury (SCI) as it reduces pro-inflammatory cytokines and chemokines, alters metabolic factors, and reduces gliosis...
2.
Haque A, Samantaray S, Knaryan V, Capone M, Hossain A, Matzelle D, et al.
Exp Neurol
. 2020 Apr;
330:113315.
PMID: 32302678
Parkinson's disease (PD), a debilitating progressive degenerative movement disorder associated with loss of dopaminergic (DA) neurons in the substantia nigra (SN), afflicts approximately one million people in the U.S., including...
3.
Johnson B, Radwan F, Hossain A, Doonan B, Hathaway-Schrader J, God J, et al.
J Cell Biochem
. 2018 Nov;
120(4):6264-6276.
PMID: 30378157
Though the current therapies are effective at clearing an early stage prostate cancer, they often fail to treat late-stage metastatic disease. We aimed to investigate the molecular mechanisms underlying the...
4.
Polcyn R, Capone M, Hossain A, Matzelle D, Banik N, Haque A
Neuroimmunol Neuroinflamm
. 2018 Feb;
4:254-257.
PMID: 29423430
No abstract available.
5.
Polcyn R, Capone M, Hossain A, Matzelle D, Banik N, Haque A
J Clin Cell Immunol
. 2018 Feb;
8(6).
PMID: 29423333
No abstract available.
6.
Hathaway-Schrader J, Doonan B, Hossain A, Radwan F, Zhang L, Haque A
J Cell Biochem
. 2017 Sep;
119(2):2212-2221.
PMID: 28857256
Melanoma represents an ever-increasing problem in the western world as incidence rates continue to climb. Though manageable during early stages, late stage metastatic disease is highly resistant to current intervention....
7.
God J, Cameron C, Figueroa J, Amria S, Hossain A, Kempkes B, et al.
J Immunol
. 2015 Jan;
194(4):1434-45.
PMID: 25595783
Elevated levels of the transcription factor c-myc are strongly associated with various cancers, and in particular B cell lymphomas. Although many of c-MYC's functions have been elucidated, its effect on...
8.
Radwan F, Hossain A, God J, Leaphart N, Elvington M, Nagarkatti M, et al.
J Cell Biochem
. 2014 Aug;
116(1):102-14.
PMID: 25142864
Lymphoma is a potentially life threatening disease. The goal of this study was to investigate the therapeutic potential of a natural triterpenoid, Ganoderic acid A (GA-A) in controlling lymphoma growth...
9.
Hossain A, Radwan F, Doonan B, God J, Zhang L, Bell P, et al.
Apoptosis
. 2012 Aug;
17(10):1066-78.
PMID: 22847295
Melanoma is the most aggressive form of skin cancer, responsible for the majority of skin cancer related deaths. Thus, the search for natural molecules which can effectively destroy tumors while...
10.
Hossain A, God J, Radwan F, Amria S, Zhao D, Bethard J, et al.
Clin Dev Immunol
. 2011 Dec;
2011:780839.
PMID: 22162713
While the defects in HLA class I-mediated Ag presentation by Burkitt lymphoma (BL) have been well documented, CD4+ T-cells are also poorly stimulated by HLA class II Ag presentation, and...